首页> 美国卫生研究院文献>Therapeutics and Clinical Risk Management >The association between methylated CDKN2A and cervical carcinogenesis and its diagnostic value in cervical cancer: a meta-analysis
【2h】

The association between methylated CDKN2A and cervical carcinogenesis and its diagnostic value in cervical cancer: a meta-analysis

机译:甲基化CDKN2A与宫颈癌发生的关系及其在宫颈癌中的诊断价值:荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundCervical cancer is the second deadliest gynecologic malignancy, characterized by apparently precancerous lesions and cervical intraepithelial neoplasia (CIN), and having a long course from the development of CIN to cervical cancer. Cyclin-dependent kinase inhibitor 2A (CDKN2A) is a well-documented tumor suppressor gene and is commonly methylated in cervical cancer. However, the relationship between methylated CDKN2A and carcinogenesis in cervical cancer is inconsistent, and the diagnostic accuracy of methylated CDKN2A is underinvestigated. In this study, we attempted to quantify the association between CDKN2A methylation and the carcinogenesis of cervical cancer, and its diagnostic power.
机译:背景宫颈癌是第二致命的妇科恶性肿瘤,其特征是明显的癌前病变和宫颈上皮内瘤样变(CIN),并且从CIN的发展到宫颈癌有很长的路要走。细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A)是一个有据可查的抑癌基因,在宫颈癌中通常被甲基化。然而,甲基化CDKN2A与宫颈癌的致癌作用之间的关系不一致,并且甲基化CDKN2A的诊断准确性尚待研究。在这项研究中,我们试图量化CDKN2A甲基化与子宫颈癌的发生之间的关联及其诊断能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号